RALBP1 and breast carcinoma: In the present study, we observed that 2HF treatment inhibits the growth of breast cancer cells in vitro, reduces the levels of RLIP76 and VEGF, and inhibits the progression of triple-negative MDA-MB-231 breast tumors in xenograft mouse model of breast cancer.